Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 655

1.

Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study.

Amrein K, Sourij H, Wagner G, Holl A, Pieber TR, Smolle KH, Stojakovic T, Schnedl C, Dobnig H.

Crit Care. 2011;15(2):R104. doi: 10.1186/cc10120.

2.

Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.

Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, Urbanic Purkart T, Waltensdorfer A, Münch A, Warnkross H, Stojakovic T, Bisping E, Toller W, Smolle KH, Berghold A, Pieber TR, Dobnig H.

JAMA. 2014 Oct 15;312(15):1520-30. doi: 10.1001/jama.2014.13204. Erratum in: JAMA. 2014 Nov 12;312(18):1932.

PMID:
25268295
3.

Efficacy and safety of high dose intramuscular or oral cholecalciferol in vitamin D deficient/insufficient elderly.

Tellioglu A, Basaran S, Guzel R, Seydaoglu G.

Maturitas. 2012 Aug;72(4):332-8. doi: 10.1016/j.maturitas.2012.04.011.

PMID:
22613271
4.

Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study.

Stricker H, Tosi Bianda F, Guidicelli-Nicolosi S, Limoni C, Colucci G.

Eur J Vasc Endovasc Surg. 2012 Sep;44(3):307-12. doi: 10.1016/j.ejvs.2012.06.023.

5.

Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting.

Hackman KL, Gagnon C, Briscoe RK, Lam S, Anpalahan M, Ebeling PR.

Med J Aust. 2010 Jun 21;192(12):686-9.

PMID:
20565345
6.

High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency.

von Restorff C, Bischoff-Ferrari HA, Theiler R.

Bone. 2009 Oct;45(4):747-9. doi: 10.1016/j.bone.2009.06.012.

PMID:
19539796
7.

Dose response to vitamin D supplementation in postmenopausal women: a randomized trial.

Gallagher JC, Sai A, Templin T 2nd, Smith L.

Ann Intern Med. 2012 Mar 20;156(6):425-37. doi: 10.7326/0003-4819-156-6-201203200-00005. Erratum in: Ann Intern Med. 2012 May 1;156(9):672.

PMID:
22431675
8.

Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?

Stoll D, Dudler J, Lamy O, Hans D, Krieg MA, Aubry-Rozier B.

Osteoporos Int. 2013 Feb;24(2):495-500. doi: 10.1007/s00198-012-1962-5.

PMID:
22426953
10.

Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.

Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1143-9. doi: 10.2215/CJN.02840312.

11.

Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration.

Grant CC, Stewart AW, Scragg R, Milne T, Rowden J, Ekeroma A, Wall C, Mitchell EA, Crengle S, Trenholme A, Crane J, Camargo CA Jr.

Pediatrics. 2014 Jan;133(1):e143-53. doi: 10.1542/peds.2013-2602.

12.

Intermittent high-dose vitamin D corrects vitamin D deficiency in adolescents: a pilot study.

Carnes J, Quinn S, Nelson M, Jones G, Winzenberg T.

Eur J Clin Nutr. 2012 Apr;66(4):530-2. doi: 10.1038/ejcn.2011.204.

PMID:
22190133
13.

Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency.

Lips P, Binkley N, Pfeifer M, Recker R, Samanta S, Cohn DA, Chandler J, Rosenberg E, Papanicolaou DA.

Am J Clin Nutr. 2010 Apr;91(4):985-91. doi: 10.3945/ajcn.2009.28113.

14.

Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).

Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, Bakker SJ, Kema IP, van Gilst WH, van Veldhuisen DJ, Hillege HL, de Boer RA.

Am Heart J. 2013 Aug;166(2):357-364.e2. doi: 10.1016/j.ahj.2013.05.009.

PMID:
23895820
15.

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

Soilu-Hänninen M, Aivo J, Lindström BM, Elovaara I, Sumelahti ML, Färkkilä M, Tienari P, Atula S, Sarasoja T, Herrala L, Keskinarkaus I, Kruger J, Kallio T, Rocca MA, Filippi M.

J Neurol Neurosurg Psychiatry. 2012 May;83(5):565-71. doi: 10.1136/jnnp-2011-301876.

PMID:
22362918
16.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

17.

Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial.

Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC, Mast DJ, Sanford PB, Sjoberg RJ.

Endocr Pract. 2009 Apr;15(3):203-12.

PMID:
19364687
18.

How deficient are vitamin D deficient critically ill patients?

Lee P.

Crit Care. 2011;15(2):154. doi: 10.1186/cc10126.

20.

Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease.

Rucker D, Tonelli M, Coles MG, Yoo S, Young K, McMahon AW.

J Nephrol. 2009 Jan-Feb;22(1):75-82.

PMID:
19229821
Items per page

Supplemental Content

Support Center